In vitro activity of the new ketolide HMR3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp

Antimicrob Agents Chemother. 1998 Dec;42(12):3279-81. doi: 10.1128/AAC.42.12.3279.

Abstract

Ninety-four erythromycin-susceptible and 107 erythromycin-resistant enterococcal strains (MIC of >/=512 microgram/ml) were inhibited by the ketolide HMR3647 at MICs of </=0.007 to 0.06 and 0.03 to 8 microgram/ml, respectively. Eighteen vanA-positive isolates and 29 high-level-penicillin-resistant isolates, all of them erythromycin resistant, were inhibited by HMR3647 at an MIC range of 0.015 to 4 microgram/ml. The new ketolide has excellent activity against Enterococcus species.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Microbial
  • Enterococcus / drug effects*
  • Enterococcus / genetics
  • Erythromycin / pharmacology
  • Ketolides*
  • Macrolides*
  • Microbial Sensitivity Tests
  • Phenotype
  • Virginiamycin / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Ketolides
  • Macrolides
  • Virginiamycin
  • Erythromycin
  • telithromycin